Tell prescription for vomiting

Reading File

Finding Sources

Searching the Web

antiemetic drugs prescription for vomiting nausea treatment guidelines

Finding Sources

Reading File

I now have comprehensive data from Rosen's Emergency Medicine. Here is the full prescription guide for vomiting:

Prescription for Vomiting (Antiemetic Therapy)

Note: The right antiemetic depends on the cause of vomiting. Below is a structured, evidence-based guide organized by clinical scenario.

Step-by-Step Approach (Adults - General/Undifferentiated Vomiting)

Step 1 - First Line:

Ondansetron (Zofran) 4 mg IV (or PO/ODT)
- Repeat 4 mg IV in 15-30 minutes if needed
- Can give up to 8-16 mg
- Caution: may prolong QT interval

Step 2 - If Ondansetron Fails:

Metoclopramide (Reglan) 10 mg IV or IM
- Repeat after 30 minutes if needed
- Caution: risk of extrapyramidal effects (dystonic reactions, tardive dyskinesia - black box warning)

Step 3 - If Both Fail (and no GI obstruction):

Droperidol 1.25 mg IV, or
Haloperidol 5 mg IV
- Repeat after 30 minutes if needed

Step 4 - Alternative if Step 3 not safe:

Prochlorperazine (Compazine) 5-10 mg IM/PO, or 2.5-10 mg IV every 4 h, or 25 mg PR every 12 h
Promethazine 12.5 mg IM or IV (diluted in 10-20 mL NS, over 10-15 min) - preferred IM (deep injection) due to risk of tissue injury if extravasation; reduce to 6.25 mg in elderly or patients on sedating drugs
Rosen's Emergency Medicine, Chapter 25

Drug Reference Table

Drug	Class	Route/Dose (Adult)	Key Side Effects
Ondansetron	5-HT3 antagonist	4-8 mg IV/PO	Headache, QT prolongation
Metoclopramide	D2 + 5-HT3 antagonist	10-20 mg IV/IM q6h	Extrapyramidal effects, tardive dyskinesia
Prochlorperazine	D1/D2 antagonist	5-10 mg IM/PO; 25 mg PR q12h	Lethargy, hypotension, EPS
Promethazine	H1 antihistamine	12.5-25 mg IM/IV/PO	Sedation, tissue necrosis (IV)
Droperidol	D2 antagonist	1.25 mg IV	QT prolongation
Haloperidol	D2 antagonist	5 mg IV	QT prolongation, EPS
Dimenhydrinate	H1 antihistamine	50 mg IV/PO/IM	Sedation

Condition-Specific Prescribing

Pregnancy (Nausea/Vomiting)

First line: Doxylamine + pyridoxine (Vitamin B6) - safest combination
Alternative: Metoclopramide or antihistamines (dimenhydrinate, promethazine)
Ondansetron: discuss risks/benefits (questionable teratogenic effects); often used second-line
Hospitalization + IV fluids for hyperemesis gravidarum

Pediatrics (Acute Gastroenteritis)

First line: Ondansetron 0.15 mg/kg IV or PO (most robust evidence; best as ODT)
- Reduces need for IV hydration and hospitalizations
- Only beneficial if at least mild dehydration is present
Second line: Prochlorperazine 0.1-0.2 mg/kg IV/PO (not in children under 2 years; max 7.5 mg/day if <14 kg, 10 mg/day if >14 kg)
Always pair with oral rehydration

Vomiting + Headache (Migraine)

First line: Metoclopramide (treats both headache and vomiting)
Avoid ondansetron first-line (can worsen headache)
Second line: Prochlorperazine
Third line: Droperidol

Opioid-Induced Vomiting

Standard antiemetics have poor efficacy
Consider opioid rotation or dose reduction
Ondansetron or promethazine may provide partial relief

Post-operative Nausea & Vomiting (PONV)

Prophylaxis: Ondansetron 4 mg IV at end of surgery + dexamethasone 4-8 mg IV
Meclizine 25 mg pre-op for motion sickness-prone patients
Rescue (if prophylaxis fails): Switch drug class (e.g., if ondansetron given, use promethazine, droperidol, or metoclopramide for rescue); 5-HT3 antagonists only effective as rescue after 6 hours

Chemotherapy-Induced Nausea & Vomiting (CINV)

Highly emetogenic regimens: Triple therapy
- 5-HT3 antagonist (ondansetron, granisetron, palonosetron) +
- NK1 antagonist (aprepitant 125 mg PO day 1, 80 mg days 2-3) +
- Dexamethasone 12 mg IV/PO
Palonosetron preferred for multi-day CINV (long half-life)
Pre-medicate with diphenhydramine if EPS risk is high

IV Fluid Support

Always give IV crystalloid (NS or LR) if vomiting is severe or signs of dehydration are present. Correct electrolytes (especially K+ and Cl-) as vomiting causes hypochloremic hypokalemic metabolic alkalosis.

When to Escalate

No response after two or more antiemetic drug classes - consider imaging to rule out bowel obstruction
Signs of peritonitis, hematemesis, altered consciousness - immediate workup
Persistent vomiting unresponsive to escalating antiemetics - admit for IV management and etiology evaluation

Disclaimer: Antiemetic prescriptions should always be tailored to the individual patient's age, comorbidities, medications, and underlying diagnosis. The doses above are for typical adult patients. Always verify contraindications before prescribing.

Odansetron dosage and interval

Finding Sources

Searching the Web

ondansetron dosage dosing interval adults children all indications

Finding Sources

Reading File

Here is the complete ondansetron dosing guide across all indications and patient groups:

Ondansetron (Zofran) - Dosage & Dosing Intervals

Adults

General / Undifferentiated Vomiting (Emergency Setting)

Route	Dose	Interval
IV	4 mg	May repeat once in 15-30 min; up to 16 mg total
PO / ODT	4-8 mg	Single dose; repeat every 8 h if needed

Post-operative Nausea & Vomiting (PONV)

Route	Dose	Timing
IV (prophylaxis)	4 mg	Single dose at end of surgery (before emergence)
PO (prophylaxis)	16 mg	1 hour before anaesthesia
IV (treatment)	4 mg	Single dose; use only after 6 h if ondansetron was given prophylactically

Moderately Emetogenic Chemotherapy

Route	Dose	Schedule
PO	8 mg	30 min before chemotherapy, then 8 mg again 8 h later, then 8 mg every 12 h for 1-2 days
IV	0.15 mg/kg (max 16 mg)	30 min before chemo, repeat at 4 h and 8 h after first dose (3 doses total)

Highly Emetogenic Chemotherapy (e.g., cisplatin ≥50 mg/m²)

Route	Dose	Schedule
PO	24 mg (single dose)	30 min before chemotherapy
IV	0.15 mg/kg (max 16 mg/dose) x 3 doses	30 min before, then at 4 h and 8 h

Maintenance after first 24 h: 8 mg PO every 8 h for up to 5 days

Radiotherapy-Induced Nausea & Vomiting

Route	Dose	Schedule
PO	8 mg	1-2 h before radiotherapy, then every 8 h; continue for up to 5 days after treatment

Pediatrics

Acute Gastroenteritis / General Vomiting

Route	Dose	Notes
IV or PO	0.15 mg/kg	Single dose; can repeat once
ODT (oral dissolving tablet)	0.15 mg/kg	Preferred formulation

Chemotherapy (ages 4-18 years)

Body Surface Area	IV dose	Oral maintenance
BSA ≤0.6 m²	1 mg over 15 min	1 mg every 4 h x 5 days
BSA 0.6-1.2 m²	2 mg over 15 min	2 mg every 4 h x 5 days
BSA >1.2 m²	8 mg over 15 min	8 mg every 12 h x 5 days
Alternative	0.15 mg/kg (max 8 mg) q4h x 3 doses	4 mg orally every 8 h x 5 days

Children aged 4-11 years: 4 mg PO 30 min before chemotherapy, repeated at 4 h and 8 h after first dose, then 4 mg every 8 h for 1-2 days.

Post-operative (Pediatric)

No established oral formulation dose for PONV in children; IV 0.1 mg/kg (max 4 mg) as a single dose is used off-label.

Special Populations

Hepatic Impairment

Mild-moderate (Child-Pugh 5-9): No dose adjustment needed
Severe (Child-Pugh ≥10): Maximum 8 mg/day (as a single oral dose)

Renal Impairment

No dose adjustment required for any degree of renal impairment

Elderly

No dose adjustment or change in frequency required; well tolerated over age 65

Key Safety Points

QT prolongation: Ondansetron prolongs the QT interval - avoid in patients with congenital long QT syndrome or those on other QT-prolonging drugs. A 2011 FDA safety announcement flagged this risk.
Serotonin syndrome: Risk increases if combined with other serotonergic drugs (SSRIs, SNRIs, tramadol, fentanyl).
Pregnancy: Teratogenic risk is debated - discuss risks and benefits; used as second-line after doxylamine + B6.
Headache: Ondansetron itself can cause headache, so it is not preferred first-line for vomiting associated with migraine.
Max single IV dose: 16 mg (FDA 2012 advisory - 32 mg single IV dose withdrawn due to QT risk).
Rosen's Emergency Medicine, Table 25.7 | Pfizer prescribing information | Mayo Clinic

This is a shared conversation. Sign in to Orris to start your own chat.